Sentiss Pharma Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 1994.
1994 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Sentiss Pharma Private Limited

Sentiss Pharma Private Limited, a active private limited company, was established on 13 January 1994 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U74899DL1994PTC056894. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹5.88 Cr.

Formerly known as Promed Exports Private Limited. It upholds a compliant status. Employing 689 professional, Its leadership includes Canakapalli Bhaktavatasala Rao (Director), Deepak Bahri (Managing Director), Mahesh Kumar Garg (Director). Past directors included Arvind Sharma, Canakapalli Bhaktavatasala Rao, Malakeezhu Krishna Gopala Krishna Pillai. It holds ₹504.85 Cr open charges and ₹795.76 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 212 Ashirwad Commercialcomplex D-I Green Park, New Delhi, Delhi, 110016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1994PTC056894

  • Registration Number

    056894

  • Incorporation Date

    13 January 1994

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹5.88 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 5.88 Cr
  • Company Age 32 Year, 29 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 504.85 Cr
  • Satisfied Charges ₹ 795.76 Cr
  • Revenue Growth **** 39.42%
  • Profit Growth **** 102.66%
  • Ebitda **** 96.36%
  • Net Worth 24.90%
  • Total Assets **** 24.44%
Company report

Sentiss Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sentiss Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sentiss Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Canakapalli Bhaktavatasala Rao Director 29 Apr 2019 Current
Deepak Bahri Managing Director 01 May 1995 Current
Mahesh Kumar Garg Director 09 Jun 2015 Current
Geeta Mathur Director 17 Jul 2017 Current
Sameer Agarwal Director 10 Feb 2025 Current
Deepak Kumar Khungar Director 21 Nov 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 19 Jul 2019 Past
Pramod Abcsdd Additional Director 25 Sep 2019 Past
Pramod Abcsdd Director 16 Sep 2010 Past
Pramod Abcsdd Additional Director 17 Sep 2022 Past
Pramod Abcsdd Director 15 Jan 2016 Past
Pramod Abcsdd Director 09 Nov 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sentiss Pharma.

Sentiss Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.42% increase. The company also saw a substantial improvement in profitability, with a 102.66% increase in profit. The company's net worth Soared by an impressive increase of 24.9%.

Sentiss Pharma revenue growth over time
Sentiss Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 39.42%
*******
*******
*******
*******
Revenue from Operations
*******
 41.93%
*******
*******
*******
*******
Total Assets
*******
 24.44%
*******
*******
*******
*******
Profit or Loss
*******
 102.66%
*******
*******
*******
*******
Net Worth
*******
 24.90%
*******
*******
*******
*******
EBITDA
*******
 96.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sentiss Pharma?

In 2023, Sentiss Pharma had a promoter holding of 99.78% and a public holding of 0.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,048,500,000.00

Satisfied Charges

₹7,957,600,000.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 315.97 Cr
  • Others : 158.88 Cr
  • Hdfc Bank Limited : 30.00 Cr
Latest Charge Details
Date Lender Amount Status
25 Nov 2025 Yes Bank Limited ₹230.97 Cr Open
15 Mar 2025 Others ₹20.00 Cr Open
26 Nov 2024 Others ₹54.88 Cr Open
28 Feb 2024 Hdfc Bank Limited ₹30.00 Cr Open
23 Sep 2023 Others ₹50.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sentiss Pharma?

Sentiss Pharma has a workforce of 689 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sentiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sentiss Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sentiss Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge with Yes Bank Limited amounted to Rs. 230.97 Cr with Charge ID 101191596 was registered on 25 Nov 2025. was documented.

  • Charges

    The activity A charge with Others of Rs. 54.88 Cr registered on 26 Nov 2024 with Charge ID 101006068 was modified on 25 Nov 2025. was completed.

  • Charges

    Progress on A charge with Yes Bank Limited of Rs. 85.00 Cr registered on 03 May 2018 with Charge ID 100185020 was modified on 25 Nov 2025. was documented.

  • Annual General Meeting

    Progress on Sentiss Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge registered on 25 Jul 2024 via Charge ID 100959360 with Canara Bank was fully satisfied on 29 Aug 2025. was completed.

  • Balance Sheet

    The activity Sentiss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sentiss Pharma Private Limited?

The CIN of Sentiss Pharma Private Limited is U74899DL1994PTC056894.

Where is Sentiss Pharma Private Limited headquartered?

Sentiss Pharma Private Limited is headquartered at 212 Ashirwad Commercialcomplex D-I Green Park, New Delhi, Delhi, 110016.

When was Sentiss Pharma Private Limited incorporated?

Sentiss Pharma Private Limited was incorporated on 13 January 1994.

Who are the current directors of Sentiss Pharma Private Limited?

The current directors of Sentiss Pharma Private Limited are

What is the primary industry of Sentiss Pharma Private Limited?

The primary industry of Sentiss Pharma Private Limited is Manufacturing.

Is Sentiss Pharma Private Limited a listed company?

Sentiss Pharma Private Limited is unlisted.

What is the capital structure of Sentiss Pharma Private Limited?

The authorized capital of Sentiss Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹5.88 Cr.

What is the compliance status of Sentiss Pharma Private Limited?

The compliance status of Sentiss Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available